Management options for dental extraction in hemophiliacs:: A study of 55 extractions (2000-2002)

被引:34
作者
Fraction, X
Pommereuil, M
Berthier, AM
Lejeune, S
Hourdin-Eude, S
Quéro, J
Mézière, X
De Mello, G
Garnier, J
机构
[1] UFR Odontol, F-35043 Rennes, France
[2] Rennes Univ Med Ctr, Dept Pathol & Oral Surg, Rennes, France
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2005年 / 99卷 / 03期
关键词
D O I
10.1016/j.tripleo.2004.06.071
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. Dental extraction in hemophiliacs is associated with a high risk of bleeding. It requires a multidisciplinary approach and stringent protocol. The current trend is to simplify these protocols. in this study we review the efficacy of a protocol using systemic treatment - factors/dihydro-D-arginine vasopressin (DDAVP) - and simplified local hemostatic measures to control bleeding, to limit patient discomfort, and to minimize hospital length of stay. Study design. This retrospective study of 55 dental extractions was performed during 19 interventions in 16 patients with hemophilia A or B to assess the efficacy of a protocol combining general management via the injection of factor concentrates or DDAVP and local hemostasis using biological glue and gelatin packing. Compressive, hemostatic splints, which have been in use by some for many years, are replaced by intermittent tranexamic acid compression during the first 3 days after surgery. Results. We recorded 6 instances of postsurgical bleeding, 4 of which occurred after the compression period. In 2 cases repetition of the local hemostasic measures was required along with the injection of an antihemophilic factor concentrate. In the other 4 cases, the patients' condition reverted to normal following injection of the factor concentrate and the reapplication of the compression. Conclusion. The adopted protocol produced a reliable outcome, limiting the duration of the hospital stay to 24 hours in most cases, and improving postsurgical comfort thanks to a combination of systemic treatment and local hemostasic measures including intermittent tranexamic acid compression.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 17 条
  • [1] TRANEXAMIC ACID AS A MOUTHWASH IN ANTICOAGULANT-TREATED PATIENTS UNDERGOING ORAL-SURGERY - AN ALTERNATIVE METHOD TO DISCONTINUING ANTICOAGULANT-THERAPY
    BOREA, G
    MONTEBUGNOLI, L
    CAPUZZI, P
    MAGELLI, C
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1993, 75 (01): : 29 - 31
  • [2] BOYAR R, 1998, HAEMOPHILIA, V4, P405
  • [3] Djulbegovic B, 1996, AM J HEMATOL, V51, P168, DOI 10.1002/(SICI)1096-8652(199602)51:2<168::AID-AJH14>3.0.CO
  • [4] 2-E
  • [5] DJULBEGOVIC B, 1995, BLOOD, V85, P598
  • [6] Harrington B, 2000, HAEMOPHILIA, V6, P7
  • [7] Fibrin sealant: Current and potential clinical applications
    Jackson, MR
    MacPhee, MJ
    Drohan, WN
    Alving, BM
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (08) : 737 - 746
  • [8] MAKRIS SP, 2000, HAEMOPHILIA, V6, P409
  • [9] MARTINOWITZ U, 1995, THROMB HAEMOSTASIS, V74, P486
  • [10] Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors
    O'Connell, N
    Mc Mahon, C
    Smith, J
    Khair, K
    Hann, I
    Liesner, R
    Smith, OP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) : 632 - 635